|
OLA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.779100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.105600E-01 |
| Normal-vs-Stage2 |
6.159500E-02 |
| Normal-vs-Stage3 |
3.749700E-02 |
| Normal-vs-Stage4 |
1.855590E-02 |
| Stage1-vs-Stage2 |
1.447370E-01 |
| Stage1-vs-Stage3 |
6.653600E-02 |
| Stage1-vs-Stage4 |
2.456300E-02 |
| Stage2-vs-Stage3 |
4.246600E-01 |
| Stage2-vs-Stage4 |
7.529800E-02 |
| Stage3-vs-Stage4 |
1.925200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.160200E-02 |
| Normal-vs-AfricanAmerican |
6.719800E-02 |
| Normal-vs-Asian |
2.083800E-01 |
| Caucasian-vs-AfricanAmerican |
7.832200E-01 |
| Caucasian-vs-Asian |
4.783000E-01 |
| AfricanAmerican-vs-Asian |
4.894000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.784400E-01 |
| Normal-vs-Female |
3.85539999999684E-05 |
| Male-vs-Female |
8.10900000000059E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.638200E-02 |
| Normal-vs-Extreme_Weight |
5.860400E-01 |
| Normal-vs-Obese |
2.074500E-02 |
| Normal-vs-Extreme_Obese |
9.286000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.820300E-02 |
| Normal_Weight-vs-Obese |
7.336600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.365760E-01 |
| Extreme_Weight-vs-Obese |
1.193920E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.910200E-01 |
| Obese-vs-Extreme_Obese |
2.915000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.844180E-02 |
| Normal-vs-Age(41-60Yrs) |
8.838700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.338000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.345200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.630200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.882900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.750400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.121400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.919000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.764600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.526000E-01 |
| Normal-VS-Type2 PRCC |
2.241700E-02 |
| Normal-VS-KIRP CIMP |
1.063880E-03 |
| Normal-VS-Unclassified PRCC |
9.806300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.166100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.059500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.402000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.198000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.666800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.399100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.340000E-01 |
| Normal-vs-N1 |
1.675910E-03 |
| Normal-vs-N2 |
2.811800E-02 |
| N0-vs-N1 |
4.876400E-03 |
| N0-vs-N2 |
3.365900E-02 |
| N1-vs-N2 |
8.328400E-01 |
|
|
